In this issue, Riaz et al., carried out a pharmacological investigation of Carvacrol against D-galactose-induced cognitive impairment in mice, Fawad and Tahir reviewed the existing and emerging therapies in amyotrophic lateral sclerosis, Jahan and colleagues did a comparative analysis of the hepatoprotective potential of Co-enzyme Q10 as a preventive and therapeutic agent in statin-induced hepatotoxicity, Sheikh et al., reviewed studies with angiotensin-converting enzyme (ACE) inhibitors; their efficacy, adverse effects, and the genetic influence on ACE inhibitors induced cough.